BioWorld Science

Oct. 10, 2018

View Archived Issues

Glycosylation of allergens increases immune tolerance following immunization

Read More

Finding improves stem cell safety

Read More

GABA impairment not down to lack of receptors in ASD

Read More

Antigen loss, CAR gain can cause resistance to CAR T therapy

Read More

Thalidomide analogue DAID safely and effectively reduces ocular neovascularization in rats

Read More

Autologous fecal microbiota transplant restores intestinal microbiota after antibiotic treatment

Read More

Olfactory ensheathing cells can deliver therapeutic transgenes to gliomas through the nasal pathway

Read More

Merck & Co. presents phase I data for RSV MAb MK-1654

Read More

Nymox reports 78-month results from phase IIb prostate cancer study of fexapotide triflutate

Read More

M72/AS01 shows efficacy in reducing tuberculosis cases in previously infected HIV-negative adults

Read More

First patient enrolled in REIMAGINE phase IIa study of vafidemstat

Read More

AgeneBio obtains grants to support phase III study of AGB-101

Read More

Cancer drugs may be repurposed for inflammation

Read More

Forskolin-induced swelling of intestinal organoids classifies cystic fibrosis disease severity

Read More

Acceleron presents preliminary phase II data for ACE-083 in patients with CMT

Read More

First-in-human data presented for branaplam in SMA type 1

Read More

Neurocrine Biosciences and Jnana collaborate to treat CNS disorders

Read More

Newly developed IgA nephropathy murine model shows autoimmune character

Read More

Wave Life Sciences to design products for rare inherited eye diseases

Read More

Biohaven licenses therapeutic antibody from University of Connecticut

Read More

Advanced Proteome Therapeutics reports preclinical finding on antibody-amanitin conjugate

Read More

Lixte submits IND for phase Ib/II trial of LB-100 in MDS

Read More

Japanese JOINUS research program opens second public recruitment offering

Read More